US 7879909
Use of Treprostinil to treat neuropathic diabetic foot ulcers
granted A61KA61K31/557A61P
Quick answer
US patent 7879909 (Use of Treprostinil to treat neuropathic diabetic foot ulcers) held by United Therapeutics Corporation expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/557, A61P, A61P17/02, A61P29/00